Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
about
Synthesis and anticancer activity of new flavonoid analogs and inconsistencies in assays related to proliferation and viability measurements.The multi-targeted tyrosine kinase inhibitor vandetanib plays a bifunctional role in non-small cell lung cancer cells.The In Vitro and In Vivo Antiangiogenic Effects of Flavokawain B.The angiogenic responses induced by release of angiogenic proteins from tumor cell-activated platelets are regulated by distinct molecular pathways.Reconstruction of an integrated genome-scale co-expression network reveals key modules involved in lung adenocarcinoma.lncRNA LOC100132354 promotes angiogenesis through VEGFA/VEGFR2 signaling pathway in lung adenocarcinoma
P2860
Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Barbigerone, an isoflavone, in ...... ugh VEGFR2 signaling pathways.
@en
Barbigerone, an isoflavone, in ...... ugh VEGFR2 signaling pathways.
@nl
type
label
Barbigerone, an isoflavone, in ...... ugh VEGFR2 signaling pathways.
@en
Barbigerone, an isoflavone, in ...... ugh VEGFR2 signaling pathways.
@nl
prefLabel
Barbigerone, an isoflavone, in ...... ugh VEGFR2 signaling pathways.
@en
Barbigerone, an isoflavone, in ...... ugh VEGFR2 signaling pathways.
@nl
P2093
P2860
P1476
Barbigerone, an isoflavone, in ...... ugh VEGFR2 signaling pathways.
@en
P2093
Aihua Peng
Lijuan Chen
Xuewei Wang
P2860
P2888
P304
P356
10.1007/S00280-012-1923-X
P577
2012-07-20T00:00:00Z